Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

Abstract Background The combined effects of diabetes mellitus (DM), admission plasma glucose (APG), and glycated hemoglobin (HbA1c) levels on predicting long-term clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary interventi...

Full description

Bibliographic Details
Main Authors: Yan Li, Xiaowen Li, Yinhua Zhang, Leimin Zhang, Qingqing Wu, Zhaorun Bai, Jin Si, Xuebing Zuo, Ning Shi, Jing Li, Xi Chu
Format: Article
Language:English
Published: BMC 2020-01-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-020-01339-x
_version_ 1818915218420400128
author Yan Li
Xiaowen Li
Yinhua Zhang
Leimin Zhang
Qingqing Wu
Zhaorun Bai
Jin Si
Xuebing Zuo
Ning Shi
Jing Li
Xi Chu
author_facet Yan Li
Xiaowen Li
Yinhua Zhang
Leimin Zhang
Qingqing Wu
Zhaorun Bai
Jin Si
Xuebing Zuo
Ning Shi
Jing Li
Xi Chu
author_sort Yan Li
collection DOAJ
description Abstract Background The combined effects of diabetes mellitus (DM), admission plasma glucose (APG), and glycated hemoglobin (HbA1c) levels on predicting long-term clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) are unknown. Therefore, we evaluated their combined effects on long-term clinical outcomes in STEMI patients treated with pPCI. Methods In total, 350 consecutive patients with STEMI undergoing pPCI were enrolled. Patients were divided into 3 groups according to DM history and APG and HbA1c levels. The cumulative rates of 24-month all-cause deaths and major adverse cardiac and cerebrovascular events (MACCEs) were calculated. Results Both the incidence of all-cause deaths and cumulative rates of MACCEs were significantly the lowest in patients without a DM history and admission HbA1c level < 6.5%. DM patients with poor glycemic control or stress hyperglycemia on admission experienced the highest rates of all-cause deaths, MACCEs, and cardiac deaths. Admission HbA1c levels, Triglyceride (TG) levels, hemoglobin levels, DM history, and admission Killip class > 1 correlated with 24-month all-cause death; HbA1c levels on admission, DM history, APG levels, history of stroke, history of coronary heart disease, and TG levels on admission were significantly associated with MACCEs through the 24-month follow-up. The predictive effects of combining DM and APG and HbA1c levels were such that for STEMI patients undergoing pPCI, DM patients with poor glycemic control or with stress hyperglycemia on admission had worse prognosis than other patients. Conclusion Strict control of glycemic status may improve the survival of patients who have both DM and coronary heart diseases.
first_indexed 2024-12-19T23:58:47Z
format Article
id doaj.art-3cbf1dcbdaac43f9b7c3b8c723eb5b3f
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-12-19T23:58:47Z
publishDate 2020-01-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-3cbf1dcbdaac43f9b7c3b8c723eb5b3f2022-12-21T20:00:54ZengBMCBMC Cardiovascular Disorders1471-22612020-01-012011810.1186/s12872-020-01339-xImpact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionYan Li0Xiaowen Li1Yinhua Zhang2Leimin Zhang3Qingqing Wu4Zhaorun Bai5Jin Si6Xuebing Zuo7Ning Shi8Jing Li9Xi Chu10Departent of Cardiology, Xuanwu hospital, Capital Medical UniversityEmergency Department, Aerospace Center HospitalDepartent of Cardiology, Xuanwu hospital, Capital Medical UniversityDepartment of internal medicine, Qinghe Substation Hospital of Beijing Municipal Administration of PrisonsDepartment of Cardiology, Beijing Luhe Hospital, Capital Medical UniversityDepartent of Cardiology, Xuanwu hospital, Capital Medical UniversityDepartent of Cardiology, Xuanwu hospital, Capital Medical UniversityDepartent of Cardiology, Xuanwu hospital, Capital Medical UniversityDepartent of Cardiology, Xuanwu hospital, Capital Medical UniversityDepartent of Cardiology, Xuanwu hospital, Capital Medical UniversityHealth Management Center, Xuanwu hospital, Capital Medical UniversityAbstract Background The combined effects of diabetes mellitus (DM), admission plasma glucose (APG), and glycated hemoglobin (HbA1c) levels on predicting long-term clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) are unknown. Therefore, we evaluated their combined effects on long-term clinical outcomes in STEMI patients treated with pPCI. Methods In total, 350 consecutive patients with STEMI undergoing pPCI were enrolled. Patients were divided into 3 groups according to DM history and APG and HbA1c levels. The cumulative rates of 24-month all-cause deaths and major adverse cardiac and cerebrovascular events (MACCEs) were calculated. Results Both the incidence of all-cause deaths and cumulative rates of MACCEs were significantly the lowest in patients without a DM history and admission HbA1c level < 6.5%. DM patients with poor glycemic control or stress hyperglycemia on admission experienced the highest rates of all-cause deaths, MACCEs, and cardiac deaths. Admission HbA1c levels, Triglyceride (TG) levels, hemoglobin levels, DM history, and admission Killip class > 1 correlated with 24-month all-cause death; HbA1c levels on admission, DM history, APG levels, history of stroke, history of coronary heart disease, and TG levels on admission were significantly associated with MACCEs through the 24-month follow-up. The predictive effects of combining DM and APG and HbA1c levels were such that for STEMI patients undergoing pPCI, DM patients with poor glycemic control or with stress hyperglycemia on admission had worse prognosis than other patients. Conclusion Strict control of glycemic status may improve the survival of patients who have both DM and coronary heart diseases.https://doi.org/10.1186/s12872-020-01339-xST-segment elevation myocardial infarctionHyperglycemiaDiabetesGlycated hemoglobinPercutaneous coronary intervention
spellingShingle Yan Li
Xiaowen Li
Yinhua Zhang
Leimin Zhang
Qingqing Wu
Zhaorun Bai
Jin Si
Xuebing Zuo
Ning Shi
Jing Li
Xi Chu
Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
BMC Cardiovascular Disorders
ST-segment elevation myocardial infarction
Hyperglycemia
Diabetes
Glycated hemoglobin
Percutaneous coronary intervention
title Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
title_full Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
title_fullStr Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
title_full_unstemmed Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
title_short Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
title_sort impact of glycemic control status on patients with st segment elevation myocardial infarction undergoing percutaneous coronary intervention
topic ST-segment elevation myocardial infarction
Hyperglycemia
Diabetes
Glycated hemoglobin
Percutaneous coronary intervention
url https://doi.org/10.1186/s12872-020-01339-x
work_keys_str_mv AT yanli impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT xiaowenli impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT yinhuazhang impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT leiminzhang impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT qingqingwu impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT zhaorunbai impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT jinsi impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT xuebingzuo impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT ningshi impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT jingli impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention
AT xichu impactofglycemiccontrolstatusonpatientswithstsegmentelevationmyocardialinfarctionundergoingpercutaneouscoronaryintervention